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ABSTRACT The binding of cyclosporine to human peripheral blood lymphocytes (PBLs) was studied by measuring the fluorescence
emission spectrum and lifetime of the fluorescent and immunosuppressive cyclosporine derivative dansyl-cyclosporine (DCs). The
emission maximum and fluorescence lifetime of DCs were characterized in several solvents. The fluorescence emission maximum and
lifetime of DCs increased at a high dielectric constant. The fluorescence lifetime decay curve of DCs was a monoexponential function in
all solvents tested. Fluorescence micrographs of lipid vesicles and erythrocytes labeled with DCs exhibit uniform staining patterns,
whereas PBLs show heterogeneous DCs labeling. DCs exhibits a relatively low emission maximum (490 nm) in erythrocyte membranes.
Such an emission maximum is characteristic of a hydrophobic environment. DCs in PBLs also has a low emission maximum (484 nm).
The lifetime of DCs in PBLs required two exponential terms to properly fit the lifetime decay curve and could not be attributed to light
scattering. One short component (4.7 ± 1.0 ns) and a second long component (18.5 ± 1.0 ns) were resolved from the DCs fluores-
cence decay curves. Time-resolved anisotropy of DCs in PBLs revealed that the labeled drug was present in an anisotropic environment,
consistent with at least some DCs being bound to a membrane. These fluorescence studies suggest that DCs interacts with multiple
and/or heterogeneous sites in peripheral blood lymphocytes.
INTRODUCTION
Cyclosporine A (CsA) is an immunosuppressive agent
(1) widely prescribed to prevent graft rejection (2, 3).
CsA interferes with an early event in T cell activation
(4-6). Unfortunately, CsA's mechanism of action re-
mains unknown (7). Since CsA is hydrophobic, it would
be expected to partition into membranes. Evidence sug-
gests that the plasma membrane is the first site of CsA
action. Changes in phospholipid metabolism oflympho-
cyte membranes have been shown to follow CsA expo-
sure (6, 8). Other investigators have detected lympho-
cyte membrane depolarization after addition ofCsA (9,
10). Raman spectroscopic and calorimetric studies have
shown that CsA lowers the partition coefficient and the
heat of activation of artificial membranes (1 1, 12). CsA
has been shown to bind to a cytosolic lymphocyte pro-
tein, termed cyclophilin, that is closely associated with
calmodulin ( 13, 14). Both tritiated CsA and the fluores-
cent CsA derivative dansyl-cyclosporine (DCs) retain im-
munosuppressive activity similar to that of native CsA,
thus making them valuable tools in the study of CsA
activity (14, 15). Fluorescence microscopy of DCs has
shown that this drug is localized at the plasma mem-
brane as well as in intracellular pools ( 16).
Fluorescent molecules are very sensitive to their envi-
ronment. The fluorescence emission maximum and fluo-
rescence lifetime can be used to measure physical differ-
ences in a probe's environment, such as hydrophobicity
( 17). Careful study of changes in the fluorescence DCs
should provide valuable information concerning cyclo-
sporine binding sites. In this study the fluorescence prop-
erties ofDCs in several known solvent systems of differ-
ing hydrophobicity are compared with those of DCs in
various membrane/cell systems, including peripheral
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blood lymphocytes. From these data, it is possible to
characterize in biophysical terms the local environment
ofDCs in cells. Additional evidence concerning the bind-
ing and rotational motion ofDCs is provided by time-re-
solved fluorescence anisotropy studies.
MATERIALS AND METHODS
Cells
Human erythrocytes and peripheral blood lymphocytes (PBLs) were
obtained from normal subjects. PBLs were isolated by step-density gra-
dient centrifugation using Ficoll-Hypaque solutions (Sigma Chemical
Co., St. Louis, MO). Lymphocytes were enriched by allowing mono-
cytes to adhere to plastic dishes for 30 min at 370C. The size, refractiv-
ity, and Geimsa staining indicated that the nonadherent population
was >90% lymphocytes. Lymphocytes were >96% viable as deter-
mined by Trypan Blue exclusion. Cells were studied at a concentration
of 2 x IO' cells/ml.
Liposomes
Artificial membranes were prepared from dimyristoylphospatidylcho-
line (DMPC). Anhydrous phospholipids (>95% pure) were obtained
from Sigma Chemical Co. and then dissolved in chloroform at milli-
molar concentrations. The lipid solutions were dried in 5-ml round-
bottom flasks using a Buchi rotavappr. One milliliter ofphosphate-buf-
fered saline (PBS) or Hank's buffered saline solution (HBSS) (pH 7.4)
was added to the flask. The flask was agitated vigorously after hydration
above the phase transition temperature. These large multilamellar lipo-
somes were prepared weekly and stored under argon gas at 40C.
Solvents and fluorophores
Technical grade solvents (chloroform, acetone, ethanol, and metha-
nol) were obtained from Fisher Scientific (Pittsburgh, PA). DCs ((n-
dansyl)-o-lysyl-8-cyclosporine) was the generous gift of Drs. Roland
Wenger, D. Romer, and E. Rissi (Sandoz, Ltd., Basel, Switzerland).
Dansylamide (5- [dimethylamino] naphthalene-l-sulfonamide) was
obtained from Sigma Chemical Co. DCs was prepared at 0.01 M in
absolute ethanol and diluted in HBSS at pH 7.4 to a final working
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concentration of 1-5 x 10-6 M (0.05% ethanol). For solvent experi-
ments, DCs (0.01 M in EtOH) was diluted in the appropriate solvent to
a final concentration of 5 x 10 -6 M. In tests of DCs in HBSS, 0.1%
Triton-X100 detergent (Sigma Chemical Co.) was added to minimize
the formation of DCs aggregates.
Fluorescence microscopy
Cells were examined in a Zeiss Axiovert 35 inverted fluorescence micro-
scope (Carl Zeiss, New York, NY) interfaced with a Perceptics Biovi-
sion system (Knoxville, TN). Differential interference contract images
were collected with a Dage-MTI charged-coupled device camera ( Mich-
igan City, IN). A Zeiss IOOX (N.A. = 1.3) objective and a condenser of
N.A. = 0.55 were used. DCs was excited using a mercury vapor lamp
and emission detected with a 419 nm emission filter. A Dage-MTI
model 66 SIT camera received the fluorescence image. Video signals
were recorded on hard disk, streaming tape, or a Sony 5850 video
recorder. Images were photographed with a Polaroid (Boston, MA)
freeze-frame video recorder.
r(t) =-Iw(t) - Ihv(t)Q d(t)I,,(t) + 2IhV(t)Q s(t) (1)
where d(t) is the difference curve and s(t) is the sum curve. Q is a total
scaling factor that corrects for the intensity of excited light transmitted
at different polarizer positions and variations in the number ofphotons
per pulse emanating from the lamp during the experiment. This factor
is
Q = GKIcr, (2)
where G = Ivh/Ihh and K = Ihv/Ivv,. The factor I, is the integrated count
ratio; the total number of counts for each curve [I,(t)IIhV(t)] are
obtained.
The angle (0) between the emission dipole and polar axis ofDCs was




Measurements of fluorescence emission spectra were performed with
an MPF-66 spectrofluorometer (Perkin-Elmer, Norwalk, CT)
equipped with a water bath. DCs was excited with 360 nm light (slit
width = 7.5 nm), and the resulting emission spectra (slit width = 10
nm) were recorded. All emission spectra (n = 5 for all solvents) were
reproducible with less than a 1.0% standard error in the emission max-
ima. 5 x 10-6 M DCs in the appropriate solvent was measured after a
45-min equilibration period. Erythrocytes and lymphocytes were incu-
bated with 1-5 x 10-6 M DCs for 1 h at 37°C and washed twice with
PBS at 37°C before analysis.
Fluorescence lifetime analysis
Fluorescence lifetimes ofDCs were measured using a fluorescence life-
time instrument (Photochemical Research Associates, Inc., London,
Ontario, Canada) using the single photon counting method for fluores-
cence lifetime determination ( 17). Excitation was provided by a thyra-
tron-gated arc lamp containing 75-85 kPa of N2 operating at 30 kHz
with a 3.5-4.0 kU potential. The 337-nm N2 emission line was selected
by a grated monochromator and used to excite DCs. The appropriate
fluorescence emission for each sample (as determined from the emis-
sion spectra) was selected by a second grated monochromator. Pulse
width (full width at half maximum) was 2.0-2.5 ns for all samples.
Scattering was <3% for all samples. Data were acquired at <2% of the
lamp repetition rate. Data containing 4-9 x 103 peak channel counts
and a 10 3-fold decay were collected in 512 channels using a multichan-
nel analyzer. Samples were maintained at a constant temperature using
a circulating water bath. For each decay curve, a corresponding lamp
profile using a scattering solution (latex beads, milk, and/or unlabeled
cells) was collected. Computer analysis deconvoluted the lamp curve
from the sample curve, and the lifetime was then calculated from the
resulting exponential decay curve. The cell concentration was 200,000
cells/ml for all experiments.
Time-resolved fluorescence
anisotropy
Time-resolved fluorescence anisotropy (TRFA) measurements were
made using the fluorescence lifetime instrument described above.
TRFA studies used a Glan-Thompson cell for selecting polarization of
excitation light and a Polaroid sheet for selecting the emission polariza-
tion ( 18). Briefly, two sets of data and lamp curves were collected for
the vertical (v) and horizontal (h) polarizer positions specified in Eq. 1.
The time dependence of the fluorescence anisotropy, r(t), is given by
(3)
where ro, is the limiting anisotropy measured from the TRFA data. The
derivation of Eq. 3 assumes that the absorption and emission dipoles
are colinear. This angle, 0, corresponds to the amount of wobble of a
membrane-bound fluorophore ( 19).
RESULTS
Photomicroscopy
Photomicroscopy of DMPC vesicles stained with 3 x
10 -6M DCs for 1 h at 37°C shows that the fluorophore is
uniformly distributed in the lipid bilayer (Fig. 1, A and
B). Cyclosporine concentrations of <IO-5 M were used
in this study due to the formation of micelles at the criti-
cal micelle concentration of 3 x 10-' M (8). A similar
distribution pattern is found for human erythrocytes
(Fig. 2, A and B). These results suggest an equivalent
partitioning of DCs among these lipid membranes. Pe-
ripheral blood lymphocytes exhibit a brighter and more
heterogeneous staining of cells (Fig. 2, C-F). Some cells
show a uniform membrane-associated DCs staining,
whereas others exhibit clustering and punctate fluores-
cence of the probe. These DCs-labeling patterns may be
associated with plasma membrane binding and an intra-
cellular compartment(s) or binding site(s) (10).
Fluorescence emission spectroscopy
Fluorescence emission spectra of DCs in various sol-
vents show a marked difference in emission maxima (Ta-
ble 1). The hydrophobicity of a solvent is related to its
dielectric constant. Dielectric constants of the solvents
used (20) are as follows: acetone (20.7), methanol
(32.6), ethanol (24.3), chloroform (4.8), and water
(80.4) (these values are the low frequency static values at
20-25°C). As Table 1 shows, the emission maxima of
DCs is affected by the dielectric constant of the solvent.
This physical property of DCs can be used as an indica-
tor of the hydrophobicity of its environment.
The emission spectra ofDCs is similar in erythrocytes
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FIGURE I Photomicrographs of DMPC multilamellar liposomes labeled with DCs. DMPC liposomes were incubated with 3 x 10-6 M DCs at
37°C for 2 h and analyzed. (A) Differential interference contrast image of the liposomes. (B) Fluorescence image of the DCs in the artificial
membranes. DCs stain DMPC liposomes in a bright and uniform manner. (x 1,000)
and PBLs. A single broad peak with a maxima at 490 nm
was found for DCs in red blood cells. A similar fluores-
cence emission spectrum was measured for DCs in PBLs
(Fig. 3). This blue shift ofthe DCs emission is similar to
the blue shifts observed for other membrane-bound
fluorophores ( 19). Similar results (Xem = 279 nm) were
obtained using DMPC vesicles. The low wavelength
emission maxima correspond to an environment that
has a low dielectric constant (i.e., chloroform: Xem = 490
nm, e = 4.8), which suggests that its environment is
largely hydrophobic.
Fluorescence lifetime measurements
A probe's fluorescence lifetime is also dependent on the
polarity of its environment. As seen in Table 1, the fluo-
rescence lifetimes of DCs in nonpolar solvents are not
readily distinguished from one another as a function of
dielectric constant ( 13.0-14.5 ns; n = 5). Distilled water
and HBSS increased the fluorescence lifetime of DCs
( 17.6 ± 2.1 ns; n = 8), which is characteristic of an
aqueous environment.
Computer analyses of fluorescence decay curves use
the least-squares method of interpreting the data (21 ).
Several statistical tests were used routinely in the analysis
of each exponential fit. In determining whether a single-
or double-exponential fit is required, the Durbin-Wat-
son (DW) test parameter was evaluated in each case.
The DW test parameter is sensitive to small nonrandom
patterns in the residuals of an exponential fit. Such a
parameter can determine whether a single or double ex-
ponential is required in fitting a fluorescence decay
curve. This statistical test is more sensitive than the X2 to
nonrandom residual patterns. Acceptable DW parame-
ters for single- and double-exponential curve fits are
> 1.65 and > 1.75, respectively. Statistical analysis of the
single exponentials determined for DCs in all solvent
and aqueous buffer runs gave acceptable DW and x2
values (ranges were DW = 1.82-2.03, X2 = 1.05-1.14).
The fluorescence decay of DCs in erythrocytes was ana-
lyzed using both single- and double-exponential curve
fitting. The single-exponential lifetime was 13.2 ± 2.3 ns
(n = 3, DW = 1.35, x 2 = 1.70), whereas the double-ex-
ponential fit gave TI = 1.3 ± 0.5 ns and T2 = 13.9 ± 4.1
ns, with amplitudes of 0.09 and 0.05, respectively
(DW = 2.1 1, X2 = 0.88). The fluorescence lifetime of
DCs in lymphocytes was different from that of the sol-
vent systems and erythrocytes (Fig. 4). Two lifetime com-
ponents were required to fit the fluorescence decay curve
of PBLs because single-exponential curve fitting of DCs
lifetime decays resulted in poor statistical correlation
(DW = 1.02 and x2 = 2.09). The double-exponential
curve fit resulted in a fast component (T, = 4.7 ± 1.0 ns)
and slow component (T2 = 18.5 ± 1.0 ns) with ampli-
tudes of 0.0 16 and 0.036, respectively (n = 9, DW =
2.01, x2 = 1.01). Similar double-exponential decays
were obtained using a lymphocyte-like cell line. The fast
component (T < 8 ns) could not be observed in DMPC
vesicles using single- or double-exponential curve fitting,
thus suggesting that it is specific for cells.
Since the double-exponential curve fitting was only
required in the presence of cells, it seemed possible that
light scattering from the cell samples might have affected
the lifetime measurements. To control for this possibil-
ity, the reagent dansylamide (T = 3.31 ± 0.013 ns in
100% ethanol; DW = 1.8, x2 = 1.17), which would not
be expected to specifically interact with cells, was used.
Sample turbidity was raised using both intact cells and
0.6-,um latex beads (Polysciences Inc., Warrington, PA).
Both ofthese types ofcontrol experiments yielded single-
exponential decays with DW parameters of 2.0 or
greater. Therefore, the required two-component fit was
not due to the label per se or light scattering artifacts
introduced by the cells. Furthermore, the lifetime hetero-
geneity likely was not due to DCs self-quenching since
our experiments were conducted at low, physiologically
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FIGURE 2 Photomicrographs of peripheral blood lymphocytes and erythrocytes stained with DCs. (A, C, and E) Differential interference contrast
images; and (B, D, and F) fluorescence micrographs ofcells stained with DCs. Erythrocytes exhibit a uniform DCs staining pattern (A and B). In B
the camera gain was increased to detect the weak DCs staining seen in erythrocytes. PBLs exhibit bright, diffuse, punctate, and dim DCs-staining
patterns (D and F). D shows that lymphocytes label much more brightly with DCs than do erythrocytes. Cells were incubated with 3 x 10-6 M DCs
for 2-4 h at 37°C and washed twice with PBS before analysis. (x 1,000)
relevant concentrations (i.e., 1-5 ,uM) that were below
its critical micelle concentration. We suggest that the
two-component fit is a reflection of an interaction be-
tween DCs and cells.
Time-resolved fluorescence
anisotropy
TRFA is sensitive to the rotational motions of a fluoro-
phore occurring near the time scale as its fluorescence
lifetime ( 18, 19). Fig. 5 is a representative TRFA plot of
peripheral blood lymphocytes labeled with DCs. The
time-dependent decay is a measure of the rotational
correlation time (3.0 ± 0.1 ns) that reflects the probe's
rotational mobility. The time-dependent component of
the TRFA is the limiting anisotropy (rm, = 0.08); it
corresponds to a dansyl cone angle that apparently is
51.50 (calculated using Eq. 3) (17, 19). The limiting
anisotropy of DCs suggests that it wobbles more than
DPH ( 18) in leukocyte membranes (this would still be
true if DCs were immobilized at a second site since rm,
would be overestimated). These anisotropy studies indi-
cate that the rotation of DCs is hindered at one or more
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TABLE 1 Properties of DCs in various solvents and cells
Solvent/sample Emission Fluorescence
(n) e maxima lifetime DW x2
nm ns
Chloroform (5) 4.8 491 14.5 ± 0.4 1.91 1.05
Acetone (5) 20.7 509 13.1 ± 0.2 2.00 1.08
Ethanol (5) 24.3 515 13.9 ± 0.1 1.82 1.14
Methanol (5) 32.6 522 13.0 ± 0.1 2.09 1.09
H20/HBSS (8) 80.4 522 17.6 ± 2.1 1.92 1.06
Erythrocytes (3) NA 490 ***13.2 ± 2.4 1.35 1.70
1,=1.3±0.3 2.11 0.88
,r= 13.9 ± 1.0
Peripheral blood
lymphocytes (9) NA 484 ***16.9 ± 1.2 1.02 2.09
= 4.7 ± 1.0 2.01 1.01
T2 = 18.5 ± 1.0
Emission spectra and fluorescence lifetimes of DCs were measured in
various solvents and test samples. Five x 10'M DCs was added to the
samples at 37°C for 1 h. Cell samples were washed twice with PBS (pH
7.4) and analyzed at 37°C. Emission spectra (10-nm slit width) were
obtained with an excitation wavelength of 360 nm (5-nm slit width).
Fluorescence lifetime decay measurements used the nitrogen-337 nm
peak for excitation. Terms used: n, number of independent runs; 6,
dielectric constant; DW, Durbin-Watson test parameter (should be
> 1.65 and >1.75 for the fluorescence decay curve fit of single and
double exponentials, respectively); NA, not applicable; and x2, chi-
square determined for the same fluorescence decay curve fit. Asterisks
(***) refer to the best single exponential fit ofthe decay curve in the cell
samples. Above data are means of all sample runs.
site(s) of localization within lymphocytes. These results










In this study we have used fluorescence techniques to
characterize the binding ofthe immunosuppressive drug
DCs to lymphocytes. Four specific fluorescence tech-
niques were used to examine the nature of DCs-binding
to PBLs. (a) Video-intensified fluorescence microscopy
of DCs showed uniform labeling of lipid vesicles and
erythrocytes, whereas lymphocytes exhibited heteroge-
neous staining patterns in PBLs. (b) Fluorescence emis-
sion maxima ofDCs in various solvents tested the sensi-
tivity ofDCs to hydrophobic environments and then the
DCs emission maxima in erythrocytes and PBLs could
then be characterized as hydrophobic. (c) DCs fluores-
cence lifetimes in solvents and cells were analyzed, and
the presence oftwo distinct lifetime components suggest
that DCs binds to a heterogeneous site or multiple sites
with different local environments in PBLs. (d) Fluores-
cence anisotropy ofDCs illustrates that at least one com-
ponent ofthe cyclosporine label moves in an anisotropic
fashion in PBLs.
Fluorescence micrographs of DCs in lymphocytes re-
vealed many different patterns of staining from uniform
plasma membrane staining to punctate staining (cyto-
solic binding sites) and combinations ofboth. It was ap-
parent from the micrographs that lymphocytes con-
tained binding sites at the plasma membrane and in the
cytosol. In contrast, micrographs oflabeled erythrocytes
and lipid vesicles exhibited only a uniform diffuse stain-
ing, possibly reflecting the exclusive binding of DCs to
these membranes.
Fluorescence Emission Wavelength (nm)
FIGURE 3 DCs emission spectra in various solvents and cells. Five x 10-6 M DCs was added to the appropriate solvent and allowed to equilibrate
for I h at 37°C. The solvents shown are chloroform (trace a), acetone (b), ethanol (c), methanol (d), and aqueous (f). PBLs are shown in trace e.
Cells were stained similarly but washed twice with PBS (pH 7.4) before analysis. Aqueous buffer samples were prepared with 0.1% Triton-X to
minimize the effects of aggregates.
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FIGURE 4 Fluorescence lifetime decay curves of DCs in solvents and cells. The dashed line (---) is the background lamp curve. The solid lines
( ) are overlapped decays of DCs in the following samples: (a) chloroform, (b) acetone, (c) ethanol, (d) methanol, (e) H20/HBSS, and (f)
peripheral blood lymphocytes. Data points (... ) are included only for the upper- and lower-most decay curves. The first 18 ns were reserved for
background counts. PBLs exhibit a unique heterogeneous DCs lifetime when compared with all other samples, including erythrocytes.
Both fluorescence emission spectra and fluorescence
lifetimes ofDCs are dependent on the hydrophobicity of
it's environment. The emission maxima ofDCs in chlo-
roform, erythrocytes, and lymphocytes are all similar
(480-490 nm), indicating hydrophobic environments
(an aqueous environment yields a DCs emission maxi-
mum = 522 nm). Comparing measurements in standard
solvent systems with those cells showed that DCs is pri-
marily localized in nonpolar environments within eryth-
rocytes and lymphocytes.
The monoexponential decay of DCs fluorescence in
all the solvents tested was expected of these homoge-
neous systems. In erythrocytes, DCs exhibited an emis-
sion maximum similar to that found for nonpolar sol-
vents, suggesting that DCs is localized in a hydrophobic
environment, apparently the lipid bilayer. The fluores-
cence lifetime decay ofDCs in erythrocytes required two
exponents for a reliable fit. Peripheral blood lympho-
cytes labeled with DCs resulted in a complex lifetime
curve that required two exponentials. But these two expo-
nentials were different from those measured for DCs in
erythrocytes. In erythrocytes, rl = 1.3 ± 0.2 and T2 =
13.9 ± 0.9 ns, whereas DCs in PBLs gave -r = 4.7 ± 1.0
and T2 = 18.5 ± 1.0 ns. If only bilayer partitioning of
DCs were involved, one would not expect such large dif-
ferences between the fluorescence lifetime decay ofDCs.
Furthermore, the short lifetime component could not be
observed in DMPC vesicles. These results support the
conclusion that the lymphocyte has DCs binding sites
that are physically, and perhaps physiologically, differ-
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FIGURE 5 TRFA ofDCs in PBLs. Cells were incubated with 5 x 10 -6M DCs for 1 h at 37°C and washed twice with PBS (pH 7.2) before analysis.
The raw data points ( ... ) and the least-squares fit ( ) are shown. The first 9 ns were reserved for background counts. This representative TRFA
plot provides direct evidence that DCs is localized in a heterogeneous and anisotropic environment when bound to PBLs (n = 3).
ent from those found in erythrocytes. For example, the
short lifetime component in cells may correspond to a
cytosolic binding protein site ( 13, 14). TRFA plots con-
firm that a population ofDCs molecules is indeed bound
to some site(s) in the lymphocyte and is not unattached.
Another possible interpretation of the data is that dif-
ferent subsets of lymphocytes are binding DCs in differ-
ent manners. Indeed, Hess and Colombani ( 14) have
shown differential DCs staining among T lymphocytes;
some cells are dim, whereas others are brightly labeled.
Other evidence presented here is also consistent with the
interpretation that more than one binding site may be
present on an individual lymphocyte. Fluorescence mi-
crographs of DCs-labeled peripheral blood lymphocytes
show most cells labeling in a heterogeneous manner (dif-
fuse and punctate staining). This is consistent with other
findings that CsA partitions into the lipid bilayer (11,
22) and also that CsA binds a cytosolic protein ( 13, 14).
The heterogeneous DCs binding sites that are found in
PBLs may reflect the physiologically relevant site(s) of
CsA action. Recent advances in streak camera technol-
ogy may make it possible to image microscopically varia-
tions in fluorescence lifetimes on a cell-by-cell basis and
within compartments of an individual cell in the near
future.
Various studies indicate that CsA alters lymphocyte
physiology by interacting with cytosolic proteins and
perturbing membrane functions. A depolarization ofthe
lymphocyte plasma membrane occurs 2-5 min after
CsA exposure ( 10) and causes lipid ordering in lympho-
cyte membranes during the same time frame (8), as well
as alterations in phospholipid metabolism (6). Evidence
presented here of heterogeneous cyclosporine binding
sites in human PBLs is consistent with the findings of
others that cyclosporine may partition into membranes
(22), forms cytosolic lipid droplets ( 16), and binds a
cytosolic protein in target cells ( 13, 14). Our results sug-
gest that cyclosporine binds to a heterogeneous site and/
or multiple physically distinct sites in living lympho-
cytes.
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